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Diagnosis of pigmented lesions of the oral cavity and perioral tissues is challenging. Even though epidemiology 
may be of some help in orientating the clinician and even though some lesions may confidently be diagnosed on 
clinical grounds alone, the definitive diagnosis usually requires histopathologic evaluation. Oral pigmentation 
can be physiological or pathological, and exogenous or endogenous. Color, location, distribution, and duration 
as well as drugs use, family history, and change in pattern are important for the differential diagnosis. Dark or 
black pigmented lesions can be focal, multifocal or diffuse macules, including entities such as racial pigmentation, 
melanotic macule, melanocytic nevus, blue nevus, smoker’s melanosis, oral melanoacanthoma, pigmentation by 
foreign bodies or induced by drugs, Peutz-Jeghers syndrome, Addison s´ disease and oral melanoma. The aim of 
this review is to present the main oral black lesions contributing to better approach of the patients.
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The color of oral pigmentation can vary depending on the 
quantity and depth or location of the pigment. Generally, 
the surface shows brown pigmentation and those located 
deeper are black or blue. Melanin is produced by melano-
cytes in the basal layer of the epithelium and is transferred 
to adjacent keratinocytes via membrane-bound organelles 
called melanosomes. Melanin is also synthesized by nevus 
cells, which are derived from the neural crest and are found 
in the skin and mucosa (1). The melanocytes are present in 
any region of the oral cavity and can be present in reactive, 
benign or malignant lesions. 
In addition, pigmentation derived from foreign bodies, 
heavy metal poisoning or drugs may also promote pig-
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mented lesions, which can vary in intensity and extension, 
and can occur in any sites of the oral cavity. The clinical 
history, symmetry and uniformity of the lesion are crucial 
in determining the clinical differential diagnosis.
-Physiological pigmentation
Physiological pigmentation is common and results from 
an increase in the production of melanin pigment by the 
melanocytes (2). Darker skinned individuals are more 
commonly affected. The color of physiological pigmen-
tation can range from light brown to almost black. Phy-
siological pigmentation increases with age, and color 
intensity can be influenced by smoking, hormones and 
systemic medications (3). The attached gingiva is the 
most common location, but physiological pigmentation 
can be noted anywhere in the oral cavity, including the 
tips of the fungiform papillae on the dorsal tongue and 
the diagnosis of physiological pigmentation normally 
is made clinically and do not need any treatment (4). 
However, when it is performed, demonstrate increased 
melanin pigmentation of the basal layer, as well as occa-
sional incontinent melanin and/or melanophages in the 
superficial lamina propria without increasing number of 
melanocytes.
-Post inflammatory pigmentation
Long-standing inflammatory mucosal diseases, such as 
oral lichen planus, pemphigus or pemphigoid can cause 
mucosal pigmentation (3). The pathogenesis of post in-
flammatory pigmentation remains unclear (5) and can 
be seen more frequently in dark-skinned individuals. 
Clinically, multiple brown–black pigmented areas are 
noted adjacent to reticular, erosive or vesicular lesions. 
Microscopically, there is increased production of mela-
nin by the melanocytes and accumulation of melanin-
laden macrophages in the superficial connective tissue 
(1). Generally, the resolution of the inflammatory pro-
cess allows the cessation of oral pigmentation.
-Melanotic macule
The oral melanotic macule is a small, well-circum-
scribed, brown-to-black that occurs commonly on the 
lips and gingiva, followed by the palate and buccal 
mucosa (Fig. 1). Patients age ranges from 4 to 98 years 
(mean 43.7) with predilection for females (1.9:1). His-
tologically, it is characterized by in situ increased pro-
duction of melanin by basal melanocytes with normal 
morphological features (6) (Fig. 1). Melanin pigment 
is also observed in melanophages in the upper portion 
of the lamina propria (6). Generally a biopsy is recom-
mended to distinguish melanotic macule from other oral 
melanocytic lesions.
-Melanocytic nevus
Melanocytic nevi are much less common on the oral 
mucosa than skin. Clinically, oral nevi are small, 
well circumscribed macules but commonly appear as 
slightly raised papules (Fig. 1). They can be brown, 
bluish-gray, or almost black and occasionally non-
pigmented (7). Regarding etiology and pathogenesis, 
most studies have focused on cutaneous lesions. It is 
now clear that melanocytic nevi constitute benign ne-
oplasms of cutaneous melanocytes, which frequently 
harbour oncogenic serine/threonine-protein kinase 
B-Raf (BRAF) or, less commonly, neuroblastoma ras 
viral oncogene homolog (NRAS) mutations. Probably, 
oncogenic mutations drive the initial hyperprolifera-
tion that results in the formation of the nevi, while a 
subsequent growth-arrest response with the features 
of oncogene-induced cellular senescence accounts for 
the cessation of further growth (8).
Different from normal melanocytes, which are regu-
larly interspersed as single cells among basal keratino-
cytes, forming the so called ‘‘epidermal-melanin unit’’, 
nevomelanocytes tend to cluster in compact so called 
theques (9). In view of the many histologic similarities, 
it seems plausible that the pathogenesis of oral melano-
cytic nevus be similar to that of the cutaneous lesions. 
Regarding morphogenesis, the melanocytic prolifera-
tion can be divided into three phases: proliferation of 
benign neoplastic melanocytes along the submucosal–
mucosal junction (junctional nevus); migration of these 
cells to the underlying mesenchymal tissue (compound 
nevus); and loss of the junctional component of the nevi, 
so that all remaining nevomelanocytes are located with-
in the subepithelial connective tissue stroma (subepithe-
lial nevus) (Fig. 1) (9).
Fig. 1. A) Labial melanotic macule. B). Increased numbers of me-
lanocytes along the junctional zone (H&E, x 200). C) Intraoral me-
lanocytic nevus located on the left buccal mucosa. D) Nevus cells 
located within the connective tissue (H&E, x 200). E) Blue nevus 
located on the right posterior hard palate. F) Blue nevus showing 
proliferation of dendritic melanocytes, elongated and spindle-shaped 
in connective tissue deep (H&E, x 100).
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There are no reports of malignant transformation of in-
traoral nevi even in patients who have had mutiple nevi 
or congenital nevi. Biopsy is strongly advisable for any 
new oral pigmentation because an early melanoma may 
be mistaken as melanocytic nevi (10).
-Blue nevus
A blue nevus is a benign, acquired melanocytic lesion 
that typically presents as an asymptomatic, slate-blue 
or blue-black smooth-surfaced macule or papule and 
usually measures less than 6 mm in diameter (Fig. 1) 
(11). The vast majority of blue nevi develops on the 
skin and has also been identified in a variety of muco-
sal sites (12). However, oral mucosa is rarely affected 
by blue nevus (13). 
The intraoral variant of blue nevus is typically identi-
fied between the third and fifth decades of life, with an 
average patient age at diagnosis of 38 years. Females 
tend to be more commonly affected than males. Two 
thirds of all intraoral blue nevi are found on the hard 
palate, and the buccal mucosa is the second most com-
mon site of presentation (12). 
Blue nevus is characterized by a variety of histologic 
subtypes, although most are classified as either “com-
mon” or “cellular” (14). The common blue nevus, which 
is the most frequent subtype seen in the oral cavity is 
characterized by an intramucosal proliferation of elon-
gated, bipolar, spindle-shaped melanocytes that are of-
ten grouped in short fascicles parallel arranged to the 
overlying epithelium (Fig. 1) (14). In contrast, a cellular 
blue nevus is usually characterized by an intramucosal, 
nodular proliferation of dendritic spindle-shaped, pig-
mented melanocytes, in addition to tightly-packed ag-
gregates of larger oval-to-round melanocytes with pale 
cytoplasm and little or no melanin (14). From a clinical 
standpoint, common blue nevi are almost always inno-
cuous lesions and rarely recur. Furthermore, rare cases 
of malignant melanoma have been reported to arise in a 
cellular blue nevi (14).  
-Smoker’s melanosis 
Smoker’s melanosis occurs in 25 to 31% of tobacco users 
and is characterized by discrete or coalescing multiple 
brown macules that usually involve the attached man-
dibular gingiva on the labial side, although pigmentation 
of the palate and buccal mucosa has also been associated 
with pipe smoking (15). Smoking-associated melanosis 
is due to increased melanin production by melanocytes 
and its deposition within the basal cell layer and lamina 
propria. The microscopic appearance of melanosis is es-
sentially similar to that seen in physiologic pigmentation 
or a melanotic macule (16). A gradual return to normal 
pigmentation over several months to years has been re-
ported following smoking cessation (17). 
-Black Hairy tongue
Black hairy tongue is a painless, benign disorder caused 
by defective desquamation and reactive hypertrophy of 
the filiform papillae of the tongue (18). The hairy ap-
pearance is due to elongation of keratinized filiform pa-
pillae that may show various colors from yellow-brown 
to black depending on extrinsic factors, ie, tobacco, 
coffee, tea, food, and intrinsic factors, ie, chromogenic 
organisms in the normal flora (19). The exact pathoge-
nesis is unclear. Precipitating factors include poor oral 
hygiene, use of the antipsychotic drug olanzapine, a 
broad spectrum of antibiotics such as erythromycin, 
and therapeutic head and neck radiation. A biopsy is 
usually not necessary for diagnosis due to the typical 
clinical presentation. Scraping or brushing the tongue 
and smoking cessation enhance the resolution of black 
hairy tongue. Trimming of the papillae may be required 
in extreme cases (20).
-Oral melanoacanthoma
Oral melanoacanthoma is a rare, benign pigmented le-
sion, brown to brown-black, well circumscribed and 
similar to cutaneous melanoacanthoma, characterized 
by hyperplasia of spinous keratinocytes and dendritic 
melanocytes (Fig. 2). The pathogenesis of oral melanoa-
canthoma remains uncertain, although its clinical beha-
vior is suggestive of a reactive origin. The most common 
intraoral sites are the buccal mucosa, lip, palate and gin-
giva. The average age of presentation is 28 years, mainly 
in blacks, with a strong female predilection (21). 
Fig. 2. A) Melanoacanthoma on the right buccal mucosa. B) Me-
lanoacanthoma showing proliferation of benign dendritic melano-
cytes scattered throughout the epithelium, acanthosis and spongiosis 
(H&E, x 100). C) Clinical aspect of amalgam tattoo on the gingival 
border bilaterally. D) Radiographic evaluation of amalgam tattoo. E) 
Oral melanoma located in gingival region. F) Histopathology of oral 
melanoma with atypical melanocytes, nuclear pleomorphism and hy-
perchromatism (H&E, x 100).
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A diagnosis of oral melanoacanthoma can be performed 
solely on the basis of the histological features and the 
lesion may regress after biopsy.  Nevertheless, in order 
to emphasize the presence of melanin Fontana-Masson 
stain can be used. The immunohistochemical profile 
of oral melanoacanthoma is essentially limited to the 
melanocytic markers, but it is not necessary for the di-
agnosis (22). Immunohistochemical studies generally 
reveal diffuse nuclear and cytoplasmic immunoreac-
tivity of the dendritic melanocytes with S-100 protein. 
These cells also exhibit moderate-to-diffuse cytoplas-
mic reactivity for HMB-45 (23). However, because of 
the heavy pigmentation of many of the dendritic cells, 
a reaction product may be difficult to visualize through 
the brown melanin. 
-Foreign bodies 
Many metals have been implicated in the production 
of pigmentation in the oral region. These include lead, 
which produces characteristic generalized cutaneous 
‘lead hue’ (described as a combination of pallor and li-
vidity), and ‘lead lines’ on the gingiva (grey areas of 
discoloration below the gingival margins), mercury 
which can cause slate-grey gingival hyperpigmentation, 
gold, bismuth and amalgam. Amalgam tattoo is caused 
by the presence of metallic material in the oral tissues. 
This most commonly follows the accidental implanta-
tion of dental filling material into the gingival or buccal 
mucosa (24). Amalgam tattoos are painless, gray-blue 
macules that range in size from a few millimeters to 
greater than 1 cm. The tattoo can be single or multiple. 
Most amalgam tattoos are located on the gingiva and 
edentulous mucosa (Fig. 2), but can also be seen on the 
hard palate, buccal mucosa, and floor of the mouth. Ra-
diographic evaluation may be positive (Fig. 2). When 
mucosal pigment exhibits a blue-gray color in a patient that 
reports a history of dental amalgam restorations of either 
primary deciduous or permanent dentition, a biopsy may 
be unnecessary (1,2,24). However, if either of these criteria 
is not met, a biopsy is indicated. On histological exami-
nation, fine black granular or fibrillar material embedded 
in the connective tissue or in a perivascular location with 
little or no inflammatory response is seen. Foreign body 
giant cell reactions are uncommon (10).
-Drugs
In predisposed patients, drugs may cause an intraoral 
inflammatory reaction and subsequently induce postin-
flammatory hyperpigmentation, a non-specific reaction 
that is the basis of pigmentary change seen in fixed drug 
reactions (25). Drugs such as arsenic can directly induce 
pigmentation by combining with sulphydryl groups in 
the epidermal cells causing promotion of the action of 
tyrosinase. Others such as the phenothiazines and mi-
nocycline may be deposited in the skin or mucosa and 
directly react with melanin to form a drug–pigment 
complex. Cotrimazole was the most common drug as-
sociated to oral pigmentation followed by tetracycline; 
however, many others have been implicated, including 
colchicines, ketoconazole, pyrimethamine and barbitu-
rates (26). Fixed drug eruptions are more commonly 
seen in people with dark skin and often present as a 
slate brown color due to pigmentary incontinence of 
melanophages in the upper dermis. Pigmented macules 
of the tongue have also been described, occurring as the 
result of a fixed drug eruption (27). 
Illicit drug use may also cause unusual areas of pig-
mentation. Westerhof et al. (28) reported striking dark 
pigmented macular areas on the dorsum of the tongue 
that they felt was the result of a fixed drug eruption fol-
lowing the inhalation of the heroin and methaqualone. 
Oral brownish pigmentation has also been reported 
in human immunodeficiency virus (HIV)-positive 
patients receiving treatment with zidovudine (AZT), 
ketoconazole and clofazamine (29).
-Peutz-Jeghers syndrome
The Peutz-Jeghers syndrome (PJS) consists of mucocu-
taneous macules, intestinal hamartomatous polyposis, 
and increased risk of carcinomas of the gastrointestinal 
tract, pancreas, breast, and thyroid. PJS has autosomal 
dominant inheritance and germline mutations in the 
STK11/LKB1 gene on 19p13.3 are found in 30–70% 
of the cases, depending on the screening method, with 
considerable uncharacterized genetic heterogeneity re-
maining in this syndrome (30). Black-to-brown spots of 
less than 1 mm in size are typically localized on the 
lower lip and in the perioral area (Fig. 3). Intraoral, in-
Fig. 3. Peutz-Jeghers syndrome: black spots localized in the perioral area.  
tranasal, conjunctival, and rectal pigmented lesions as 
well as spots localized on the acral surfaces may also 
be present (1,3). The oral lesions are benign and his-
tologically characterized by an increase in melanin in 
the basal layer, without an obviously increased number 
of melanocytes (3). A fading or a disappearance of the 
spots is usually observed in older age (31). 
-Addison s´ disease and other endocrine disorders
Addison s´ disease, is characterized by deficient pro-
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duction of hormones of the adrenal cortex, leading to 
increased production of adrenocorticotropic hormone 
(ACTH) (32). This may result in a diffuse dark pig-
mentation of the skin and the oral mucosa (1). Other 
signs and symptoms of Addison’s disease include 
anorexia, nausea, and postural hypotension. Lips, 
gingiva, buccal mucosa, hard palate, and tongue are 
usually involved. Pigmented lesions may be diffuse 
or localized and usually precede skin manifestations. 
Diffuse or discrete pigmentations of the lips and 
oral mucosa are sometimes observed in monostotic 
and polyostotic fibrous dysplasia (McCune-Albright 
syndrome), hyperthyroidism, and Nelson syndrome. 
Treatment of pigmented lesions of the oral mucosa 
associated with a systemic disorder is usually not re-
quired. The disappearance of oral lesions may follow 
the treatment of the underlying condition (1,32).
-Oral melanoma
Oral melanoma is rare, accounting for less than 1% of 
all oral malignancies. It is characterized by proliferation 
of malignant melanocytes along the junction between 
the epithelial and connective tissues, as well as within 
the connective tissue. The most common site is the hard 
palate, which accounts for about 40% of cases, followed 
by the gingiva (Fig. 2), which accounts for one third of 
cases. Other oral mucosal sites may also be affected. 
Oral melanoma is generally encountered between the 
fourth and seventh decades of life, with a greater inci-
dence in men than in women. Clinically, oral melanoma 
may present as an asymptomatic, slow-growing brown 
or black patch with asymmetric and irregular borders or 
as a rapidly enlarging mass associated with ulceration, 
bleeding, pain and bone destruction. In approximately 
one-third of the cases, oral melanomas are characte-
rized by a prolonged radial growth phase followed by 
a vertical growth phase; whereas others exhibit a faster 
progression into a vertical growth phase (33). 
Histologically, the radial growth phase represents in situ 
and superficial melanoma and the vertical growth phase 
represent the nodular or invasive melanoma (34) (Fig. 
2). The oral melanoma is not subdivided into the classi-
cal cutaneous melanoma categories, which include su-
perficial spreading melanoma, nodular melanoma and 
acral lentiginous melanoma (34). The histologic micro-
staging system of Clark, used in cutaneous melanoma, 
cannot be applied to oral mucosa, because of the lack of 
histologic landmarks analogous to papillary and reticu-
lar dermis (34). The Tumor-Nodes-Metastasis clinical 
staging system (TNM) for oral melanoma recognizes 
three stages: stage I, primary tumor (T any N0 M0); 
stage II, metastatic tumor to regional lymph nodes (T 
any N1 M0); stage III, metastatic tumor to distant sites 
(T any N any M1) (35).
Treatment involves radical surgical excision with clear 
margins. This may be difficult to accomplish because of 
anatomic constraints and proximity to vital structures. 
Radiation and chemotherapy are ineffective, which adds 
to the difficulties associated with management of this 
malignancy. Distant metastases often affect the lungs, 
brain, liver, or bones. The prognosis for patients with oral 
melanoma is much worse than for those with cutaneous 
lesions, and the overall 5-year survival rate is 15% (36).
Discussion
Diagnosis of pigmented lesions of the oral cavity and 
perioral tissues is challenging (1,37). Generally, the 
clinical aspects of pigmented lesions in the oral cavity 
are sufficient in establishing the diagnosis. However, in 
some cases, biopsy is necessary and occasionally, im-
munohistochemical stains such as melanocyte marker 
HMB-45 and macrophage marker CD68 may be re-
quired to prompt a correct diagnosis. 
The ABCD checklist (asymmetry, border irregularities, 
color variegation, and diameter > 6 mm) that is common-
ly used to aid the identification of cutaneous melanoma 
may be of some utility in the clinical diagnosis of oral 
melanoma (38). Location on the palate increases the rate 
of suspicion of melanoma and usually requires a biopsy. 
Solitary pigmented melanocytic lesions of the oral mu-
cosa include oral melanotic macule, oral melanoacan-
thoma, melanocytic nevus, atypical melanocytic hy-
perplasia/proliferation, and melanoma (39). Melanotic 
macules are the most common lesions, affecting mainly 
the lip and gingiva, corresponding to 86.1% of solitary 
melanocytic lesions of the mouth (39). Oral melanoa-
canthoma is usually a solitary lesion but multiple and 
bilateral lesions in the buccal mucosa have been report-
ed (22). The oral lesions generally regress after removal 
of traumatic irritants or after excisional biopsy. 
Oral melanocytic pigmentations have been reported in 
patients with Laugier-Hunziker syndrome (idiopathic 
lenticular mucocutaneous pigmentations) and with 
Carney complex (spotty skin pigmentations, myxomas 
and endocrine overactivity). Human immunodeficien-
cy virus infection has been associated with multiple 
usually well circumscribed melanotic macules locali-
zed on the buccal and palatal mucosa, gingiva, and lips 
(40). However, the association may be only coinciden-
tal. The histopathologic appearance is similar to clas-
sical melanotic macules. It remains unclear whether 
such pigmentations are caused by the virus, therapy, 
or other factors (3). 
Chronic inflammatory conditions, such as oral lichen 
planus, pemphigus, pemphigoid, and chronic periodon-
tal disease, are sometimes associated with deposition 
of melanin within the connective tissue, resulting in a 
darkening of the mucosal area (3,37). The presence of 
lesions resembling melanotic macules of the palate in 
patients with lung diseases, including cancer, also has 
been reported, but there is lack of evidence of a true as-
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sociation. Melanin production and stimulation may also 
sometimes follow surgical procedures (37).
Many pigmented lesions can be clinically diagnosed based 
on size, shape, or color, along with the clinical information. 
Developing a differential diagnosis is imperative for a clini-
cian faced with these lesions in order to appropriately treat 
the patient. Therefore, the establishment of effective clinical 
maneuvers in front of pigmented lesions of oral mucosa is 
crucial in the exclusion of possible malignancies.
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